Australian Clinical Labs Limited

ASX:ACL Stock Report

Mkt Cap: AU$610.5m

Australian Clinical Labs Past Performance

How has Australian Clinical Labs performed over the past 5 years?

Past Performance Score

6/6

Past Performance Score 6/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


49.2%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: ACL has high quality earnings.

Growing Profit Margin: ACL's current net profit margins (17.9%) are higher than last year (9.3%).


Past Earnings Growth Analysis

Earnings Trend: ACL has become profitable over the past 5 years, growing earnings by 49.2% per year.

Accelerating Growth: ACL's earnings growth over the past year (195.2%) exceeds its 5-year average (49.2% per year).

Earnings vs Industry: ACL earnings growth over the past year (195.2%) exceeded the Healthcare industry -7.9%.


Return on Equity

High ROE: ACL's Return on Equity (76.7%) is considered outstanding.


Return on Assets


Return on Capital Employed


Discover strong past performing companies